The Asia Pacific Medical Image Analysis Software Market would witness market growth of 12.1% CAGR during the forecast period (2022-2028).
Public and private organizations' growing investments in healthcare facilities create market expansion potential. An increase in the number of people with cancer and other chronic conditions is projected to outpace the market's demand for medical image analysis software. The rising need for a diagnostic imaging software and the expanding use of ultrasound equipment to obtain quicker findings, particularly in chronic diseases, are other key factors driving this market.
Another significant factor is the requirement for medical image analysis software in numerous fields, such as biomedical research & clinical practice, by various professionals, such as biologists who produce 3D confocal microscopy datasets by studying cells, virologists who produce 3D reconstructions of viruses, radiologists who quantify tumors from MRIs & CT scans for cancer detection using functional magnetic resonance imaging, and by PET technologists who measure regional cerebral metabolic activity.
The manufacturers' demand for powerful computer tools for quantification and visualization is therefore being focused on in addition to developments in the hardware and systems used to generate medical images, boosting the market expansion.
The prevalence of orthopedic injuries is increasing as a result of the increase in motor vehicle incidents, which is driving up the demand for more sophisticated imaging equipment and a more sophisticated healthcare system. The growing middle class, the ageing population, the rise in lifestyle diseases, and the increased use of digital technology are all factors in expanding the Indian healthcare sector. In addition, the nation's government has also created several policies intended to encourage foreign direct investment and a variety of structural reforms targeted at supporting the healthcare sector (FDI). These elements will contribute to expanding the medical image analysis software market in the Asia-Pacific region.
The China market dominated the Asia Pacific Medical Image Analysis Software Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $556.8 million by 2028. The Japan market is estimated to grow a CAGR of 11.4% during (2022 - 2028). Additionally, The India market would experience a CAGR of 12.8% during (2022 - 2028).
Based on Type, the market is segmented into Integrated and Standalone. Based on Modality, the market is segmented into Computed Tomography, Ultrasound, Magnetic Resonance Imaging, Combined Modalities and Others. Based on End User, the market is segmented into Hospitals, Diagnostic Centers and Others. Based on Application, the market is segmented into Cardiology, Orthopedic, Neurology, Dental, Oncology and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Medical Image Analysis Software Market is Projected to reach USD 6.6 Billion by 2028, at a CAGR of 11.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Canon, Inc. (Canon Medical Systems Corporation), Koninklijke Philips N.V., GE HealthCare Technologies, Inc., Siemens Healthineers AG (Siemens AG), Spacelabs Healthcare (OSI Systems, Inc.), Agfa-Gevaert Group, MIM Software, Inc., Esaote SpA, Aquilab SAS (Coexya), and Merative L.P. (Francisco Partner).
By Type
By Modality
By End User
By Application
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
